<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
    <title>New York, NY Medical Malpractice Blog | Rheingold, Valet, Rheingold, Shkolnik &amp; McCartney LLP</title>
    <link rel="alternate" type="text/html" href="http://www.rheingoldlaw.com/blog/" />
    <link rel="self" type="application/atom+xml" href="http://www.rheingoldlaw.com/blog/atom.xml" />
    <id>tag:www.rheingoldlaw.com,2009-12-03:/blog/241</id>
    <updated>2010-07-30T20:58:50Z</updated>
    
    <generator uri="http://www.sixapart.com/movabletype/">Movable Type Enterprise 4.32-en</generator>

<entry>
    <title>NJ Superior Consolidates Reglan Litigation</title>
    <link rel="alternate" type="text/html" href="http://www.rheingoldlaw.com/blog/2010/07/nj-superior-consolidates-reglan-litigation.shtml" />
    <id>tag:www.rheingoldlaw.com,2010:/blog//241.19701</id>

    <published>2010-07-30T20:45:27Z</published>
    <updated>2010-07-30T20:58:50Z</updated>

    <summary>In a move our firm has been long anticipating the Reglan litigation has finally been consolidated in New Jersey Superior Court under Judge Carol Higbee. Our firm is handling a number of cases that will now be centrally managed in...</summary>
    <author>
        <name>David Rheingold</name>
        <uri>http://www.rheingoldlaw.com/mt-bin/mt-cp.cgi?__mode=view&amp;blog_id=241&amp;id=461</uri>
    </author>
    
        <category term="Drugs" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Product Liability" scheme="http://www.sixapart.com/ns/types#category" />
    
    <category term="drugs" label="Drugs" scheme="http://www.sixapart.com/ns/types#tag" />
    <category term="productliability" label="Product Liability" scheme="http://www.sixapart.com/ns/types#tag" />
    
    <content type="html" xml:lang="en-us" xml:base="http://www.rheingoldlaw.com/blog/">
        <![CDATA[<p>In a move our firm has been long anticipating the <a href="http://www.rheingoldlaw.com/Drugs-Overview/Reglan-Maxolon-Degan-Maxeran-Primperan-Pylomid-Metoclopramide.shtml">Reglan </a>litigation has finally been consolidated in New Jersey Superior Court under Judge Carol Higbee. Our firm is handling a number of cases that will now be centrally managed in Atlantic County.</p>
<p>If you have taken <a href="http://www.rheingoldlaw.com/Drugs-Overview/Reglan-Maxolon-Degan-Maxeran-Primperan-Pylomid-Metoclopramide.shtml">Reglan </a>or <a href="http://www.rheingoldlaw.com/Drugs-Overview/Reglan-Maxolon-Degan-Maxeran-Primperan-Pylomid-Metoclopramide.shtml">metoclopramide </a>and have been diagnosed with&nbsp;tardive dyskensia or another disorder that's been linked to your Reglan use <a href="http://www.rheingoldlaw.com/Contact.shtml">contact </a>Rheingold, Valet, Rheingold, Shkolnik &amp; McCartney to speak with an experienced New York <a href="http://www.rheingoldlaw.com/General-Product-Liability-Overview/">drug </a>product <a href="http://www.rheingoldlaw.com/General-Product-Liability-Overview/">liability</a> attorney.</p>]]>
        
    </content>
</entry>

<entry>
    <title>Fatal Medication Errors Peak in July</title>
    <link rel="alternate" type="text/html" href="http://www.rheingoldlaw.com/blog/2010/07/fatal-medication-errors-peak-in-july.shtml" />
    <id>tag:www.rheingoldlaw.com,2010:/blog//241.18842</id>

    <published>2010-07-23T06:33:00Z</published>
    <updated>2010-07-23T06:33:44Z</updated>

    <summary> ABC reports an old saying among some doctors: do not let your friends and family schedule surgery in July. New residents, fresh out of medical school, report to their teaching hospitals in July after graduation. Researchers from the University...</summary>
    <author>
        <name>Rheingold, Valet, Rheingold, Shkolnik &amp; McCartney LLP</name>
        <uri>http://www.rheingoldlaw.com/mt-bin/mt-cp.cgi?__mode=view&amp;blog_id=241&amp;id=461</uri>
    </author>
    
    
    <content type="html" xml:lang="en-us" xml:base="http://www.rheingoldlaw.com/blog/">
        <![CDATA[ <p>
  ABC reports an old saying among some doctors: do not let  your friends and family schedule surgery in July. New residents, fresh out of  medical school, report to their teaching hospitals in July after graduation.  Researchers from the University of California recently confirmed anecdotal  evidence of the "July Effect" -- a rise in medical errors.</p><p>
  The study examined more than 62 million death certificates  from across the United States, dated from 1979 to 2006. Of those, 244,388 were  caused by medication errors in a hospital. The statistical likelihood of a  fatal medication error was virtually equal for all months except for the month  of July at teaching hospitals. In counties with a high number of teaching  hospitals, the study found that fatal medication errors spiked by 10 percent in  July, while it stayed the same in areas without teaching hospitals. The study  findings are reported in the Journal of General Internal Medicine.</p><p>
  Dr. Joanne Conroy, chief health care officer for the  Association of Medical Colleges, agreed that July is a hectic month but adds  that there are a lot of new caregivers in July. She states that July is  "probably a time where there are a lot of health professionals assuming new  responsibilities. Everybody moves up."</p><p>
  Dr. David Orentlicher, a medical doctor and professor of law  at Indiana University, told ABC that there are many aspects of starting a new  residency that might put people at risk for medical errors, including  residents' inexperience, sleep deprivation and need to learn a new hospital  system. He suggests the use of computer software to assist in checking for  prescription or dosing errors.</p>
]]>
        
    </content>
</entry>

<entry>
    <title>Study Links Half of Infection Deaths Directly to Hospital Care</title>
    <link rel="alternate" type="text/html" href="http://www.rheingoldlaw.com/blog/2010/07/study-links-half-of-infection-deaths-directly-to-hospital-care.shtml" />
    <id>tag:www.rheingoldlaw.com,2010:/blog//241.18881</id>

    <published>2010-07-23T06:30:19Z</published>
    <updated>2010-07-23T06:31:08Z</updated>

    <summary> According to a recent study published in the Archives of Internal Medicine, sepsis and pneumonia acquired in hospitals may kill 48,000 people or more each year in the United States. Both infections can often be prevented with appropriate infection...</summary>
    <author>
        <name>Rheingold, Valet, Rheingold, Shkolnik &amp; McCartney LLP</name>
        <uri>http://www.rheingoldlaw.com/mt-bin/mt-cp.cgi?__mode=view&amp;blog_id=241&amp;id=461</uri>
    </author>
    
    
    <content type="html" xml:lang="en-us" xml:base="http://www.rheingoldlaw.com/blog/">
        <![CDATA[ <p>
  According to a recent study published in the Archives of  Internal Medicine, sepsis and pneumonia acquired in hospitals may kill 48,000  people or more each year in the United States. Both infections can often be  prevented with appropriate infection control practices in hospitals.</p><p>
  Ramanan Laxminarayan, of the study, reported that it is the  first to link about half of all infection deaths directly to infections  acquired in the course of care in hospitals. As opposed to the Centers for  Disease Control and Prevention (CDC) estimates, the study calculates deaths  caused by, not merely associated with, hospital-acquired infections.  Additionally, the CDC figures are based on voluntary hospital reporting, while  the new study results are based on data regarding patient diagnoses, hospital  treatment and pre-admission exposure to infections. The researchers analyzed 69  million discharge records from hospitals in 40 states between 1998 and 2006.</p><p>
  The study estimates that hospital-acquired sepsis and  pneumonia added $8.1 billion to health care costs in 2006 alone. Medicare and  many state Medicaid programs have announced decisions to reduce or eliminate  payment for re-hospitalization or care made necessary by preventable  complications such as infections. However, even this financial incentive may be  insufficient to spur better infection control for hospitals as administrators  weigh the immediate costs of implementing infection prevention measures.  Private insurers may also increasingly amend their policies to exclude coverage  for avoidable events.</p><p>
  Proactive patients may want to inquire about hospital  checklists, policies and statistics related to hospital-acquired infections.</p>

]]>
        
    </content>
</entry>

<entry>
    <title>New York Grand Jury Subpoenas Toyota</title>
    <link rel="alternate" type="text/html" href="http://www.rheingoldlaw.com/blog/2010/07/new-york-grand-jury-subpoenas-toyota.shtml" />
    <id>tag:www.rheingoldlaw.com,2010:/blog//241.18506</id>

    <published>2010-07-20T14:54:44Z</published>
    <updated>2010-07-20T16:42:41Z</updated>

    <summary>A New York Grand Jury has subpoened Toyota to submit document relating to problem with the steering relay rods. The company said that the subpoena did not specify which models or production year, but did say they are different than...</summary>
    <author>
        <name>David Rheingold</name>
        <uri>http://www.rheingoldlaw.com/mt-bin/mt-cp.cgi?__mode=view&amp;blog_id=241&amp;id=461</uri>
    </author>
    
    <category term="recall" label="Recall" scheme="http://www.sixapart.com/ns/types#tag" />
    <category term="toyota" label="Toyota" scheme="http://www.sixapart.com/ns/types#tag" />
    
    <content type="html" xml:lang="en-us" xml:base="http://www.rheingoldlaw.com/blog/">
        <![CDATA[<p>A New York Grand Jury has subpoened Toyota to submit document relating to problem with the steering relay rods. The company said that the subpoena did not specify which models or production year, but did say they are different than those involved in <a href="http://www.rheingoldlaw.com/Auto-Products-Liability-Overview/Toyota-Sudden-Unintended-Acceleration.shtml">sudden unintended acceleration</a>. </p>
<p>In 2005 Toyota recalled nearly 1 million trucks due to faulty relay rods. Subsequent to that there have been a number of recalls involving floormats, pedals, and other mechanical problems. </p>
<p>If you have been injured as a result of a manufacturing defect in a Toyota car, <a href="http://www.rheingoldlaw.com/Contact.shtml">contact </a>Rheingold, Valet, Rheingold, Shkolnik &amp; McCartney LLP for a free consultation</p>]]>
        
    </content>
</entry>

<entry>
    <title>Redline Bicycles Recalled over Frame Failures</title>
    <link rel="alternate" type="text/html" href="http://www.rheingoldlaw.com/blog/2010/07/redline-bicycles-recalled-over-frame-failures.shtml" />
    <id>tag:www.rheingoldlaw.com,2010:/blog//241.18415</id>

    <published>2010-07-19T18:42:03Z</published>
    <updated>2010-07-19T18:50:28Z</updated>

    <summary>Seattle Bike Supply and the Consumer Product Safety Commission (CPSC) have recalled 2010 Redline Conquest Cyclocross bicycles and framesets after it was found that the fork leg can detach from the fork crown causing riders to lose control. There are...</summary>
    <author>
        <name>David Rheingold</name>
        <uri>http://www.rheingoldlaw.com/mt-bin/mt-cp.cgi?__mode=view&amp;blog_id=241&amp;id=461</uri>
    </author>
    
        <category term="Product Liability" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Recalls" scheme="http://www.sixapart.com/ns/types#category" />
    
    <category term="bicycleframefailure" label="Bicycle Frame Failure" scheme="http://www.sixapart.com/ns/types#tag" />
    <category term="productliability" label="Product Liability" scheme="http://www.sixapart.com/ns/types#tag" />
    <category term="recall" label="Recall" scheme="http://www.sixapart.com/ns/types#tag" />
    
    <content type="html" xml:lang="en-us" xml:base="http://www.rheingoldlaw.com/blog/">
        <![CDATA[<p>Seattle Bike Supply and the Consumer Product Safety Commission (CPSC) have recalled 2010 Redline Conquest Cyclocross bicycles and framesets after it was found that the fork leg can detach from the fork crown causing riders to lose control. There are 330 bicycles and framesets involved in the recall.</p>
<p>Owners are advised to stop riding the bicycles and contact their local bike dealers for a replacement. </p>
<p>Rheingold, Valet, Rheingold, Shkolnik &amp; McCartney are experienced in <a href="http://www.rheingoldlaw.com/General-Product-Liability-Overview/Bicycle-Frame-Failure.shtml">bike frame failure</a> litigation and are handling multiple cases in which bike riders have been seriously injured. If you have been seriously injured after your bike frame failed causing you to fall, <a href="http://www.rheingoldlaw.com/Contact.shtml">contact </a>an attorney at Rheingold, Valet, Rheingold, Shkolnik &amp; McCartney to speak with a New York <a href="http://www.rheingoldlaw.com/General-Product-Liability-Overview/">product liability lawyer</a> handling cases all over the country. </p>]]>
        
    </content>
</entry>

<entry>
    <title>Glaxo to pay 460 Million to Settle Most Avandia Cases</title>
    <link rel="alternate" type="text/html" href="http://www.rheingoldlaw.com/blog/2010/07/glaxo-to-pay-460-million-to-settle-most-avandia-cases.shtml" />
    <id>tag:www.rheingoldlaw.com,2010:/blog//241.17896</id>

    <published>2010-07-14T17:44:18Z</published>
    <updated>2010-07-14T17:53:39Z</updated>

    <summary>GlaxoSmithKline has agreed to pay $460 Million dollar to settle roughly 12 thousand lawsuits that have been filed over Avandia, a diabetes pill. The worst case scenario that Glaxo had outlined was paying $500,000 for all of the claims which...</summary>
    <author>
        <name>David Rheingold</name>
        <uri>http://www.rheingoldlaw.com/mt-bin/mt-cp.cgi?__mode=view&amp;blog_id=241&amp;id=461</uri>
    </author>
    
        <category term="Drugs" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Product Liability" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Recalls" scheme="http://www.sixapart.com/ns/types#category" />
    
    <category term="drugs" label="Drugs" scheme="http://www.sixapart.com/ns/types#tag" />
    <category term="productliability" label="Product Liability" scheme="http://www.sixapart.com/ns/types#tag" />
    <category term="recall" label="Recall" scheme="http://www.sixapart.com/ns/types#tag" />
    
    <content type="html" xml:lang="en-us" xml:base="http://www.rheingoldlaw.com/blog/">
        <![CDATA[<p>GlaxoSmithKline has agreed to pay $460 Million dollar to settle roughly 12 thousand lawsuits that have been filed over Avandia, a diabetes pill. The worst case scenario that Glaxo had outlined was paying $500,000 for all of the claims which would've totaled $6 billion. </p>
<p>An FDA advisory committee will vote today on whether or not to withdraw Avandia from the market after there has been concern about the cardiovascular risks associated with the <a href="http://www.rheingoldlaw.com/Drugs-Overview/">drug</a>. There has been much speculation about how the drug was approved, and whether information was excluded in order to win teh approval from the FDA. </p>
<p>The attorneys at Rheingold, Valet, Rheingold, Shkolnik &amp; McCartney are experienced <a href="http://www.rheingoldlaw.com/General-Product-Liability-Overview/">product liability</a> lawyers who have handled multiple drug manufacturer liability cases. We this news closely to see if the drug will be withdrawn from the market. <a href="http://www.rheingoldlaw.com/Contact.shtml">Contact </a>us if you believe you have been injured as a result of the harmful side effect from a drug to speak with a lawyer to help protect your rights. </p>]]>
        
    </content>
</entry>

<entry>
    <title>Suprise! Qnexa(Phentermine &amp; Topiramate) Causes Side Effects. </title>
    <link rel="alternate" type="text/html" href="http://www.rheingoldlaw.com/blog/2010/07/suprise-qnexaphentermine-topiramate-causes-side-effects.shtml" />
    <id>tag:www.rheingoldlaw.com,2010:/blog//241.17828</id>

    <published>2010-07-13T16:49:43Z</published>
    <updated>2010-07-13T17:06:59Z</updated>

    <summary><![CDATA[Briefing documents released Tuesday show that the Qnexa, which is a combination of Phentermine (one of the ingredients in FenPhen) and Topiramate (a seizure med that may&nbsp;increase suicide market as Topamax), may have harmful psychiatric and cardiovascular side effects. Qnexa...]]></summary>
    <author>
        <name>David Rheingold</name>
        <uri>http://www.rheingoldlaw.com/mt-bin/mt-cp.cgi?__mode=view&amp;blog_id=241&amp;id=461</uri>
    </author>
    
        <category term="Drugs" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Product Liability" scheme="http://www.sixapart.com/ns/types#category" />
    
    <category term="drugs" label="Drugs" scheme="http://www.sixapart.com/ns/types#tag" />
    <category term="productliability" label="Product Liability" scheme="http://www.sixapart.com/ns/types#tag" />
    
    <content type="html" xml:lang="en-us" xml:base="http://www.rheingoldlaw.com/blog/">
        <![CDATA[<p>Briefing documents released Tuesday show that the Qnexa, which is a combination of Phentermine (one of the ingredients in <a href="http://www.rheingoldlaw.com/Drugs-Overview/Diet-Drugs.shtml">FenPhen</a>) and Topiramate (a seizure med that may&nbsp;increase suicide market as Topamax), may have harmful psychiatric and cardiovascular side effects. </p>
<p>Qnexa is being review by an agency panel Thursday. The main concern currently is that there hasn't been enough testing among pregnant women, which may lead to an increase in fetal deformities. </p>
<p>Rheingold, Valet, Rheingold, Shkolnik &amp; McCartney was deeply involved in the FenPhen litigation and if this drug recieves approval we will be following it closely. <a href="http://www.rheingoldlaw.com/Contact.shtml">Contact </a>us for a free consultation if you think you have been injured as a result of a prescription <a href="http://www.rheingoldlaw.com/Drugs-Overview/">drug</a>.</p>]]>
        
    </content>
</entry>

<entry>
    <title>Bike Recall Over Fork Failure</title>
    <link rel="alternate" type="text/html" href="http://www.rheingoldlaw.com/blog/2010/07/bike-recall-over-fork-failure.shtml" />
    <id>tag:www.rheingoldlaw.com,2010:/blog//241.17826</id>

    <published>2010-07-13T16:41:18Z</published>
    <updated>2010-07-13T16:48:09Z</updated>

    <summary>The Consumer Product Safety Commision (CPSC) has annouced the voluntary recall of 100 Eastside Fix Bicycle forks because the front fork can break, posing a hazard to riders and others around them. Consumers have been advised to stop riding these...</summary>
    <author>
        <name>David Rheingold</name>
        <uri>http://www.rheingoldlaw.com/mt-bin/mt-cp.cgi?__mode=view&amp;blog_id=241&amp;id=461</uri>
    </author>
    
        <category term="Product Liability" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Recalls" scheme="http://www.sixapart.com/ns/types#category" />
    
    <category term="bicycleframefailure" label="Bicycle Frame Failure" scheme="http://www.sixapart.com/ns/types#tag" />
    <category term="productliability" label="Product Liability" scheme="http://www.sixapart.com/ns/types#tag" />
    <category term="recall" label="Recall" scheme="http://www.sixapart.com/ns/types#tag" />
    
    <content type="html" xml:lang="en-us" xml:base="http://www.rheingoldlaw.com/blog/">
        <![CDATA[<p>The Consumer Product Safety Commision (CPSC) has annouced the voluntary recall of 100 Eastside Fix Bicycle forks because the front fork can <a href="http://www.rheingoldlaw.com/General-Product-Liability-Overview/Bicycle-Frame-Failure.shtml">break</a>, posing a hazard to riders and others around them. </p>
<p>Consumers have been advised to stop riding these bicycles and contact their local Campus Cruisers dealer for a repair. </p>
<p>Rheingold, Valet, Rheingold, Shkolnik &amp; McCartney LLP have been handling defective bike frame cases for quite some time.&nbsp; If you have been injured as the result of a bike fram failure <a href="http://www.rheingoldlaw.com/Contact.shtml">contact</a>&nbsp;us for a free consultation.</p>]]>
        
    </content>
</entry>

<entry>
    <title>Toyota Recalls 270,000 Lexus Sedans</title>
    <link rel="alternate" type="text/html" href="http://www.rheingoldlaw.com/blog/2010/07/toyota-recalls-270000-lexus-sedans.shtml" />
    <id>tag:www.rheingoldlaw.com,2010:/blog//241.16284</id>

    <published>2010-07-02T13:38:10Z</published>
    <updated>2010-07-02T14:19:08Z</updated>

    <summary><![CDATA[Toyota issued a recall of&nbsp;270,000 Lexus sedans after an issue with the engine had been reported. The manufacturer has not said how they are going to fix vehicles subject to the recall. Some owners reported of a strange noise coming...]]></summary>
    <author>
        <name>David Rheingold</name>
        <uri>http://www.rheingoldlaw.com/mt-bin/mt-cp.cgi?__mode=view&amp;blog_id=241&amp;id=461</uri>
    </author>
    
        <category term="Auto Product Liability" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Product Liability" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Recalls" scheme="http://www.sixapart.com/ns/types#category" />
    
    <category term="autoproductliability" label="Auto Product Liability" scheme="http://www.sixapart.com/ns/types#tag" />
    <category term="recall" label="Recall" scheme="http://www.sixapart.com/ns/types#tag" />
    <category term="toyota" label="Toyota" scheme="http://www.sixapart.com/ns/types#tag" />
    
    <content type="html" xml:lang="en-us" xml:base="http://www.rheingoldlaw.com/blog/">
        <![CDATA[<p><a href="http://www.rheingoldlaw.com/Auto-Products-Liability-Overview/Toyota-Sudden-Unintended-Acceleration.shtml">Toyota </a>issued a recall of&nbsp;270,000 Lexus sedans after an issue with the engine had been reported. The manufacturer has not said how they are going to fix vehicles subject to the recall. Some owners reported of a strange noise coming from their engines, and other reported their engines would <a href="http://www.rheingoldlaw.com/Auto-Products-Liability-Overview/Automotive-Crashworthiness-Stability-Control.shtml">stall </a>while driving. </p>
<p>This recall comes on the tail end of another recall that was issued because of the potential for excessive fuel spilling during rear end collisions which would lead to<a href="http://www.rheingoldlaw.com/Auto-Products-Liability-Overview/Fires-Post-Collision-Fuel-Fed-Fires-in-Cars-and-Heavy-Trucks.shtml"> fires</a>. </p>
<p>If you have been injured as a result of a defective <a href="http://www.rheingoldlaw.com/Auto-Products-Liability-Overview/Toyota-Sudden-Unintended-Acceleration.shtml">Toyota </a>vehicle <a href="http://www.rheingoldlaw.com/Contact.shtml">call </a>the lawyers at Rheingold, Valet, Rheingold, Shkolnik, &amp; <a href="http://www.rheingoldlaw.com/Our-Qualifications/Terrence-E-Mccartney.shtml">McCartney </a>LLP to speak with an experienced <a href="http://www.rheingoldlaw.com/Auto-Products-Liability-Overview/">auto</a> <a href="http://www.rheingoldlaw.com/Product-Liability-Overview/">product liability</a> attorney.</p>]]>
        
    </content>
</entry>

<entry>
    <title>VA Exposes 1,812 Veterans to HIV and Other Infections</title>
    <link rel="alternate" type="text/html" href="http://www.rheingoldlaw.com/blog/2010/06/va-exposes-1812-veterans-to-hiv-and-other-infections.shtml" />
    <id>tag:www.rheingoldlaw.com,2010:/blog//241.16056</id>

    <published>2010-06-30T18:59:54Z</published>
    <updated>2010-06-30T19:11:15Z</updated>

    <summary><![CDATA[A&nbsp;VA Hospital in Missouri may have exposed 1,812 Veterans to HIV and other virus' such as hepatitis C as a result of improperly cleaning instruments. Certain dental technicians had handwashed dental instruments before putting them into cleaning machines. The technicians...]]></summary>
    <author>
        <name>David Rheingold</name>
        <uri>http://www.rheingoldlaw.com/mt-bin/mt-cp.cgi?__mode=view&amp;blog_id=241&amp;id=461</uri>
    </author>
    
        <category term="Medical Malpractice" scheme="http://www.sixapart.com/ns/types#category" />
    
    <category term="medicalmalpractice" label="Medical Malpractice" scheme="http://www.sixapart.com/ns/types#tag" />
    
    <content type="html" xml:lang="en-us" xml:base="http://www.rheingoldlaw.com/blog/">
        <![CDATA[<p>A&nbsp;VA Hospital in Missouri may have exposed 1,812 Veterans to HIV and other virus' such as hepatitis C as a result of improperly cleaning instruments. Certain dental technicians had handwashed dental instruments before putting them into cleaning machines. The technicians were not supposed to handwash the tools, only to put them in the cleaning machines.</p>
<p>Cases of improperly handling medical instruments and spreading infections have received increased attention ever since the case of a Las Vegas area endoscopy center exposing thousands to hepatitis C. The first case that went to trial came back with a judgement of over $500 million dollar against the defendants. Our firm was been extensively involved in the Las Vegas Endoscopy litigation. </p>
<p>If you have been exposed to infections as a result of a <a href="http://www.rheingoldlaw.com/Medical-Malpractice-Overview/">negligent doctor</a> or technician <a href="http://www.rheingoldlaw.com/Contact.shtml">contact </a>the lawyers at Rheingold, Valet, Rheingold, Shkolnik, &amp; McCartney to discuss your rights. </p>]]>
        
    </content>
</entry>

<entry>
    <title>Toyota Recalls ANOTHER Vehicle</title>
    <link rel="alternate" type="text/html" href="http://www.rheingoldlaw.com/blog/2010/06/toyota-recalls-another-vehicle.shtml" />
    <id>tag:www.rheingoldlaw.com,2010:/blog//241.16054</id>

    <published>2010-06-30T18:48:59Z</published>
    <updated>2010-06-30T18:58:08Z</updated>

    <summary>The National Highway Traffic Safety Administration announced the recall of the Lexus HS 250h hybrid vehicles because of the risk that fuel can leak from the car during rear end collisions which may result in fires. There is currently no...</summary>
    <author>
        <name>David Rheingold</name>
        <uri>http://www.rheingoldlaw.com/mt-bin/mt-cp.cgi?__mode=view&amp;blog_id=241&amp;id=461</uri>
    </author>
    
        <category term="Auto Product Liability" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Product Liability" scheme="http://www.sixapart.com/ns/types#category" />
    
    <category term="autoproductliability" label="Auto Product Liability" scheme="http://www.sixapart.com/ns/types#tag" />
    <category term="toyota" label="Toyota" scheme="http://www.sixapart.com/ns/types#tag" />
    
    <content type="html" xml:lang="en-us" xml:base="http://www.rheingoldlaw.com/blog/">
        <![CDATA[<p>The National Highway Traffic Safety Administration announced the recall of the Lexus HS 250h hybrid vehicles because of the risk that fuel can leak from the car during rear end collisions which may result in fires. There is currently no fix for the defect.</p>
<p>The lawyers at Rheingold, Valet, Rheingold, Shkolnik, &amp; McCartney have been working on <a href="http://www.rheingoldlaw.com/Auto-Products-Liability-Overview/">auto product liability cases</a> for years. Members of our firm are <a href="http://www.rheingoldlaw.com/blog/2010/05/hunter-shkolnik-appointed-to-position-in-toyota-class-action-1.shtml">deeply</a> involved in <a href="http://www.rheingoldlaw.com/Auto-Products-Liability-Overview/Toyota-Sudden-Unintended-Acceleration.shtml">Toyota Sudden Unintended Acceleration</a> cases as well as other instance where people have been injured from a product that was subsequently recalled by its manufacturer. If you have been hurt by a defective product <a href="http://www.rheingoldlaw.com/Contact.shtml">contact</a> us today for a free consultation. </p>]]>
        
    </content>
</entry>

<entry>
    <title>Merck Loses Fosamax Case: 8 Million in Compensatory Damages</title>
    <link rel="alternate" type="text/html" href="http://www.rheingoldlaw.com/blog/2010/06/merck-loses-fosamax-case-8-million-in-compensatory-damages.shtml" />
    <id>tag:www.rheingoldlaw.com,2010:/blog//241.15584</id>

    <published>2010-06-25T21:14:45Z</published>
    <updated>2010-06-25T21:22:49Z</updated>

    <summary>In the second bellweather trial a jury awarded 8 million dollars in compensatory damages to Shirley Boles for damages she incurred as a result of taking the osteoporosis drug Fosamax. Ms. Boles sued Merck because she developed osteonecrosis of the...</summary>
    <author>
        <name>David Rheingold</name>
        <uri>http://www.rheingoldlaw.com/mt-bin/mt-cp.cgi?__mode=view&amp;blog_id=241&amp;id=461</uri>
    </author>
    
        <category term="Drugs" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Product Liability" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Verdicts &amp; Settlements" scheme="http://www.sixapart.com/ns/types#category" />
    
    <category term="drugs" label="Drugs" scheme="http://www.sixapart.com/ns/types#tag" />
    <category term="productliability" label="Product Liability" scheme="http://www.sixapart.com/ns/types#tag" />
    <category term="verdictsampsettlements" label="<![CDATA[Verdicts &amp; Settlements]]>" scheme="http://www.sixapart.com/ns/types#tag" />
    
    <content type="html" xml:lang="en-us" xml:base="http://www.rheingoldlaw.com/blog/">
        <![CDATA[<p>In the second bellweather trial a jury awarded 8 million dollars in compensatory damages to Shirley Boles for damages she incurred as a result of taking the osteoporosis drug <a href="http://www.rheingoldlaw.com/Drugs-Overview/Fosamax-Zometa-Aredia.shtml">Fosamax</a>. Ms. Boles sued Merck because she developed osteonecrosis of the jaw after taking <a href="http://www.rheingoldlaw.com/Drugs-Overview/Fosamax-Zometa-Aredia.shtml">Fosamax</a>.</p>
<p>Merck will appeal the verdict but this is a good sign for the 1417 plaintiffs that have filed suits against Merck in federal and state courts for similiar problems. </p>
<p>If you have taken <a href="http://www.rheingoldlaw.com/Drugs-Overview/Fosamax-Zometa-Aredia.shtml">Fosamax </a>and have developed osteonecrosis of the jaw or have suffered from a femur fracture <a href="http://www.rheingoldlaw.com/Contact.shtml">contact </a>the an experienced attorney at Rheingold, Valet, Rheingold, Shkolnik &amp; McCartney. </p>]]>
        
    </content>
</entry>

<entry>
    <title>Omniscan, Magnevisit, and OptiMARK Cause Most NSF Cases</title>
    <link rel="alternate" type="text/html" href="http://www.rheingoldlaw.com/blog/2010/06/omniscan-magnevisit-and-optimark-cause-most-nsf-cases.shtml" />
    <id>tag:www.rheingoldlaw.com,2010:/blog//241.15555</id>

    <published>2010-06-25T16:49:38Z</published>
    <updated>2010-06-25T17:07:17Z</updated>

    <summary><![CDATA[The American College of Radiology reported that Omniscan, Magnevisit, and OptiMARK are associated with the highest number of nephrogenic systemic fibrosis (NSF) cases. These three MRI contrast agents contain Gadolinium and&nbsp;are manufactured by GE Healthcare, Bayer Healthcare Pharmaceuticals, and Covidien...]]></summary>
    <author>
        <name>David Rheingold</name>
        <uri>http://www.rheingoldlaw.com/mt-bin/mt-cp.cgi?__mode=view&amp;blog_id=241&amp;id=461</uri>
    </author>
    
        <category term="Product Liability" scheme="http://www.sixapart.com/ns/types#category" />
    
    <category term="drugs" label="Drugs" scheme="http://www.sixapart.com/ns/types#tag" />
    <category term="productliability" label="Product Liability" scheme="http://www.sixapart.com/ns/types#tag" />
    
    <content type="html" xml:lang="en-us" xml:base="http://www.rheingoldlaw.com/blog/">
        <![CDATA[<p>The American College of Radiology reported that <a href="http://www.rheingoldlaw.com/Drugs-Overview/Omniscan.shtml">Omniscan</a>, Magnevisit, and OptiMARK are associated with the highest number of nephrogenic systemic fibrosis (NSF) cases. These three MRI contrast agents contain <a href="http://www.rheingoldlaw.com/Drugs-Overview/Gadolinium.shtml">Gadolinium </a>and&nbsp;are manufactured by GE Healthcare, Bayer Healthcare Pharmaceuticals, and Covidien respectively. </p>
<p>The ACR reccomends that these contrast agents not be used in people with kidney disease, and that doctors should obtain renal function tests on their patients at least six weeks prior to performing their MRIs. </p>
<p>NSF&nbsp;is a disease that causes the excessive formation of connective&nbsp;tissue which can cause severe stiffness in joints and can lead to death.&nbsp;There&nbsp;are no effective&nbsp;treatments for NSF. &nbsp;</p>
<p>Our firm has been involved in <a href="http://www.rheingoldlaw.com/Drugs-Overview/Gadolinium.shtml">MRI contrast agent</a> litigation for quite some time. If you have been injured by <a href="http://www.rheingoldlaw.com/Drugs-Overview/Omniscan.shtml">Omniscan</a>, Magnevisit, OptiMARK or another MRI contrast agent <a href="http://www.rheingoldlaw.com/Contact.shtml">contact </a>the experienced <a href="http://www.rheingoldlaw.com/Product-Liability-Overview/">product liability</a> attorneys at Rheingold, Valet, Rheingold, Shkolnik &amp; McCartney to speak with a lawyer for a free consultation.</p>]]>
        
    </content>
</entry>

<entry>
    <title>Antibiotic-Resistant Staph Infections on the Rise</title>
    <link rel="alternate" type="text/html" href="http://www.rheingoldlaw.com/blog/2010/06/antibiotic-resistant-staph-infections-on-the-rise.shtml" />
    <id>tag:www.rheingoldlaw.com,2010:/blog//241.15461</id>

    <published>2010-06-24T12:17:56Z</published>
    <updated>2010-06-24T12:21:19Z</updated>

    <summary> Health officials once considered MRSA (methicillin-resistant staphylococcus aureus) a low-level threat and the infection was usually contracted only in hospitals, nursing homes and other health care facilities. Recently, however, it has become far more common in children&apos;s hospitals and...</summary>
    <author>
        <name>Rheingold, Valet, Rheingold, Shkolnik &amp; McCartney LLP</name>
        <uri>http://www.rheingoldlaw.com/mt-bin/mt-cp.cgi?__mode=view&amp;blog_id=241&amp;id=461</uri>
    </author>
    
    
    <content type="html" xml:lang="en-us" xml:base="http://www.rheingoldlaw.com/blog/">
        <![CDATA[ <p>Health officials once considered MRSA (methicillin-resistant staphylococcus aureus) a low-level threat and the infection was usually contracted only in hospitals, nursing homes and other health care facilities. Recently, however, it has become far more common in children's hospitals and in the community at large.</p>

<h3><strong>MRSA Types</strong></h3>

<p>There are two types of MRSA, one acquired in medical institutions (called hospital-associated, or HA-MRSA) and another acquired in the outside world (called community-associated, or CA-MRSA). Both types are resistant to antibiotics and are therefore more dangerous than other staph infections.</p>
 <p>
 In hospital-associated MRSA infections, the bacteria are spread during surgery and other medical testing and treatment procedures. Organ and bone transplants, for example, often result in MRSA. Those with weakened immune systems, including children and the elderly, are particularly vulnerable.</p>
 <p>
 MRSA can also be spread in the community through skin contact, which places kids and adults who play team sports at increased risk of infection. The same is true for those who live in crowded residences with unsanitary conditions.</p>

<h3><strong>How MRSA Spreads</strong></h3>

<p>The spread of MRSA can happen quickly and occurs through skin contact, medical tubing, surgical procedures and a variety of other means. In community-associated MRSA, the bacteria are often spread when an infected person comes into contact with someone else, particularly at the site of the infection.</p>
 <p>
 The initial stages of MRSA often resemble pimples or other skin abrasions, so it is not always diagnosed quickly. This leads to more exposure and allows the infection to advance to its more advanced stages.</p>

<h3><strong>Liability for MRSA</strong></h3>

<p>In some cases of MRSA infection, liability may be an issue. For example, if a physician uses improperly sterilized equipment or fails to follow proper procedures while performing surgery or inserting medical tubing, he or she may be legally liable for the patient's injuries.</p>
 <p>
 If you believe that you or a loved one has contracted MRSA because of a physician's negligence, it is important to seek legal counsel immediately. An attorney can advise you of your options and investigate your claims to find out if a medical malpractice or wrongful death lawsuit is warranted.</p>]]>
        
    </content>
</entry>

<entry>
    <title>Mylotarg Withdrawn from the Market Over Safety Issues</title>
    <link rel="alternate" type="text/html" href="http://www.rheingoldlaw.com/blog/2010/06/mylotarg-withdrawn-from-the-market-over-safety-issues.shtml" />
    <id>tag:www.rheingoldlaw.com,2010:/blog//241.15166</id>

    <published>2010-06-22T21:28:05Z</published>
    <updated>2010-06-22T21:38:03Z</updated>

    <summary>The FDA announced that Pfizer will withdraw Mylotarg from the market in October after recent clinical studies have shown that the drug may not be effective and poses greater risks than benefits to patients. The drug was used in patients...</summary>
    <author>
        <name>David Rheingold</name>
        <uri>http://www.rheingoldlaw.com/mt-bin/mt-cp.cgi?__mode=view&amp;blog_id=241&amp;id=461</uri>
    </author>
    
        <category term="Drugs" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Product Liability" scheme="http://www.sixapart.com/ns/types#category" />
    
        <category term="Recalls" scheme="http://www.sixapart.com/ns/types#category" />
    
    <category term="drugs" label="Drugs" scheme="http://www.sixapart.com/ns/types#tag" />
    <category term="productliability" label="Product Liability" scheme="http://www.sixapart.com/ns/types#tag" />
    <category term="recall" label="Recall" scheme="http://www.sixapart.com/ns/types#tag" />
    
    <content type="html" xml:lang="en-us" xml:base="http://www.rheingoldlaw.com/blog/">
        <![CDATA[The FDA announced that Pfizer will withdraw Mylotarg from the market in October after recent clinical studies have shown that the drug may not be effective and poses greater risks than benefits to patients. The drug was used in patients with acute myeloid leukemia. Read the FDA's notice <a href="http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm216458.htm">here</a>.<br /><br />The accelerated approval process employed by Pfizer was designed to bring drugs to patients with serious life threatening diseases, however clinical trials for this drug have shown that there is an increase rate of death in the first couple months of treatment. This is the first drug to be withdrawn from the market after using the abbreviated approval process. <br /><br /><a href="http://www.rheingoldlaw.com/Contact.shtml">Contact </a>Rheingold, Valet, Rheingold, Shkolnik, &amp; McCartney if you have been injured by a dangerous drug, for a free consultation.<br /> ]]>
        
    </content>
</entry>

</feed>

